Specific immunotherapy for food allergy:: basic principles and clinical aspects

被引:7
作者
Enrique, Ernesto
Cistero-Bahima, Anna
机构
[1] Hop Gen Castellon, Div Allergy, Castellon de La Plana, Spain
[2] Univ Autonoma Barcelona, Inst Univ Dexeus, E-08193 Barcelona, Spain
关键词
allergen-specific immunotherapy; anti-immunoglobulin E immunotherapy; food allergy; herbal medicine; mutated allergen; sublingual immunotherapy;
D O I
10.1097/01.all.0000246618.41871.a4
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review Food allergy may be life threatening and its management continues to consist of avoiding relevant allergens and, in the case of accidental ingestion, initiation of appropriate emergency therapy. The aim of this article is to describe current treatment approaches and discuss attempts to use specific immunotherapy for food-allergy treatment. Recent findings A recent study reports the use of sublingual immunotherapy for hazelnut food allergy in hazelnut-allergic patients. A significant increase in tolerance to hazelnuts after sublingual immunotherapy as assessed by double-blind, placebo-controlled food challenge, and good tolerance to this treatment, have been observed. Summary The purpose of this review is to highlight the most promising novel approaches for treating food allergy beyond allergen avoidance. Some of these approaches alone, such as traditional Chinese herbal medicine, anti-immunoglobulin E therapy or sublingual immunotherapy for food allergy, or the combination of different approaches, would probably offer the best treatment option for food-allergic patients in the near future.
引用
收藏
页码:466 / 469
页数:4
相关论文
共 46 条
[1]   Comparative analysis of nasal and oral mucosa dendritic cells [J].
Allam, JP ;
Niederhagen, B ;
Bücheler, M ;
Appel, T ;
Betten, H ;
Bieber, T ;
Bergé, S ;
Novak, N .
ALLERGY, 2006, 61 (02) :166-172
[2]   Characterization of dendritic cells from human oral mucosa:: A new Langerhans' cell type with high constitutive Fcε_RI expression [J].
Allam, JP ;
Novak, N ;
Fuchs, C ;
Asen, S ;
Bergé, S ;
Appel, T ;
Geiger, E ;
Kochan, JP ;
Bieber, T .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (01) :141-148
[3]  
[Anonymous], 1996, WHO TECHN REP SER
[4]  
Asero R, 1998, CLIN EXP ALLERGY, V28, P1368, DOI 10.1046/j.1365-2222.1998.00399.x
[5]   Fennel, cucumber, and melon allergy successfully treated with pollen-specific injection immunotherapy [J].
Asero, R .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 84 (04) :460-462
[6]   Component-resolved diagnosis with recombinant allergens in patients with cherry allergy [J].
Ballmer-Weber, BK ;
Scheurer, S ;
Fritsche, P ;
Enrique, E ;
Cistero-Bahima, A ;
Haase, T ;
Wüthrich, B .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (01) :167-173
[7]   Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy [J].
Batard, T ;
Didierlaurent, A ;
Chabre, H ;
Mothes, N ;
Bussières, L ;
Bohle, B ;
Couret, MN ;
Ball, T ;
Lemoine, P ;
Tejkl, MF ;
Chenal, A ;
Clément, G ;
Dupont, F ;
Valent, P ;
Krauth, MT ;
André, C ;
Valenta, R ;
Moingeon, P .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2005, 136 (03) :239-249
[8]   Allergen-specific sublingual immunotherapy: less mystic, more scientific [J].
Bieber, T .
ALLERGY, 2006, 61 (02) :149-150
[9]   A mutant of the major apple allergen, Mal d 1, demonstrating hypo-allergenicity in the target organ by double-blind placebo-controlled food challenge [J].
Bolhaar, STHP ;
Zuidmeer, L ;
Ma, Y ;
Ferreira, F ;
Bruijnzeel-Koomen, CAFM ;
Hoffmann-Sommergruber, K ;
van Ree, R ;
Knulst, AC .
CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (12) :1638-1644
[10]   Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges [J].
Bolhaar, STHP ;
Tiemessen, MM ;
Zuidmeer, L ;
van Leeuwen, A ;
Hoffmann-Sommergruber, K ;
Bruijnzeel-Koomen, CAFM ;
Taams, LS ;
Knol, EF ;
van Hoffen, E ;
van Ree, R ;
Knulst, AC .
CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (05) :761-769